Literature DB >> 26763024

Inter-rater agreement analysis of the Precise Diagnostic Score for suspected transient ischemic attack.

Carlo W Cereda1, Paul M George2, Manabu Inoue2, Nirali Vora2, Jean-Marc Olivot3, Neil Schwartz2, Maarten G Lansberg2, Stephanie Kemp2, Michael Mlynash2, Gregory W Albers2.   

Abstract

BACKGROUND: No definitive criteria are available to confirm the diagnosis of transient ischemic attack. Inter-rater agreement between physicians regarding the diagnosis of transient ischemic attack is low, even among vascular neurologists. We developed the Precise Diagnostic Score, a diagnostic score that consists of discrete and well-defined clinical and imaging parameters, and investigated inter-rater agreement in patients with suspected transient ischemic attack.
METHODS: Fellowship-trained vascular neurologists, blinded to final diagnosis, independently reviewed retrospectively identical history, physical examination, routine diagnostic studies, and brain magnetic resonance imaging (diffusion and perfusion images) from consecutive patients with suspected transient ischemic attack. Each patient was rated using the 8-point Precise Diagnostic Score score, composed of a clinical score (0-4 points) and an imaging score (0-4 points). The composite Precise Diagnostic Score determines a Precise Diagnostic Score Likelihood of Brain Ischemia Scale: 0-1 = unlikely, 2 = possible, 3 = probable, 4-8 = very likely.
RESULTS: Three raters reviewed data from 114 patients. Using Precise Diagnostic Score, all three raters scored a similar percentage of the clinical events as being "probable" or "very likely" caused by brain ischemia: 57, 55, and 58%. Agreement was high for both total Precise Diagnostic Score (intraclass correlation coefficient of 0.94) and for the Likelihood of Brain Ischemia Scale (agreement coefficient of 0.84).
CONCLUSIONS: Compared with prior studies, inter-rater agreement for the diagnosis of transient brain ischemia appears substantially improved with the Precise Diagnostic Score scoring system. This score is the first to include specific criteria to assess the clinical relevance of diffusion-weighted imaging and perfusion lesions and supports the added value of magnetic resonance imaging for assessing patients with suspected transient ischemic attack.
© 2016 World Stroke Organization.

Entities:  

Keywords:  Transient ischemic attack; acute stroke; brain; diagnosis (MesH); magnetic resonance imaging

Mesh:

Year:  2016        PMID: 26763024     DOI: 10.1177/1747493015607507

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  5 in total

1.  Pre-existing White Matter Hyperintensity Lesion Burden and Diagnostic Certainty of Transient Ischemic Attack.

Authors:  Muhammad Nagy; Muhammad U Azeem; Youssef Soliman; Sahil A Nawab; Adalia H Jun-O'Connell; Richard P Goddeau; Majaz Moonis; Brian Silver; Nils Henninger
Journal:  J Stroke Cerebrovasc Dis       Date:  2019-01-07       Impact factor: 2.136

2.  Stroke Mimics in the Acute Setting: Role of Multimodal CT Protocol.

Authors:  E Prodi; L Danieli; C Manno; A Pagnamenta; E Pravatà; L Roccatagliata; C Städler; C W Cereda; A Cianfoni
Journal:  AJNR Am J Neuroradiol       Date:  2021-12-30       Impact factor: 3.825

Review 3.  Emergency Department (ED) Triage for Transient Ischemic Attack (TIA).

Authors:  Carlo W Cereda; Jean-Marc Olivot
Journal:  Curr Atheroscler Rep       Date:  2018-09-25       Impact factor: 5.113

4.  Diagnostic Accuracy of the Explicit Diagnostic Criteria for Transient Ischemic Attack: A Validation Study.

Authors:  L Servaas Dolmans; Elena R Lebedeva; Dinusha Veluponnar; Ewoud J van Dijk; Paul J Nederkoorn; Arno W Hoes; Frans H Rutten; Jes Olesen; L Jaap Kappelle
Journal:  Stroke       Date:  2019-06-20       Impact factor: 7.914

5.  Risk factors of perfusion and diffusion abnormalities on MRI in hemispheric TIA: a case-control study.

Authors:  Yue Wang; Jingjing Xiao; Yu Luo; Shaoshi Wang; Huazheng Liang; Lingjing Jin
Journal:  Ann Transl Med       Date:  2019-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.